Crossmark

Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokines

Crossref DOI link: https://doi.org/10.1007/s10787-022-00945-9

Published Online: 2022-03-10

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sur, Debjeet https://orcid.org/0000-0001-5525-5156
Dutta, Arpan

Mondal, Chaitali

Banerjee, Apurba

Haldar, Pallab Kanti

Maji, Himangshu Sekhar

Bala, Asis
License Information

Text and Data Mining valid from 2022-03-10

Version of Record valid from 2022-03-10
More Information

Article History

Received: 23 November 2021

Accepted: 14 February 2022

First Online: 10 March 2022

Declarations

:

: We declare that we have no conflict of interest.

Document is current

Any future updates will be listed below